Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the “Merck for Mothers” global program to prevent maternal mortality and the Merck Foundation. She joined Merck in January 2010 as president of Merck Vaccines and led efforts to make the company’s vaccines more available and affordable to people in resource-limited countries around the world.
Gerberding in the news: mercknewsroom.com/news-release...
Dr. Gerberding’s talk at #APSA17 will be on Saturday, April 22nd at 4:00-4:30pm.
Register today! Early bird pricing ends March 10.
More info: meeting.physicianscientists.or...
Dr. Gerberding’s legacy at the CDC: healthimpactnews.com/2015/form...
Dr. Gerberding’s talk at #APSA17 is at 4:00-4:30pm on 4/22
-
Like
Easy one-click social registration
Is this safe?We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.
ORWhy we require registering to vote
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.
Log in or create an account to comment
Social Login
Email Login
Log in via Email
Back to Social Login
Create Your Account